InsidersTradesSigma
Track the 睿昂基因 stock price and the full management transaction log of the company, a publicly traded company based in China. Shares are quoted on CN CN, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 睿昂基因 has recorded 2 insider filings. Market capitalisation: €1.5bn. The latest transaction was reported on 12 September 2023 (Sale). Among the most active insiders: 柯中和. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.